Use of safety-modified retroviruses to introduce chemotherapy resistance sequences into normal hematopoietic cells for chemoprotection during the therapy of ovarian cancer: a pilot trial.
1996
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
6
References
71
Citations
NaN
KQI